RYHIX Performance — Health Care Fund, Investor Class
Data updated: 2026-08-28
RYHIX returned +5.68% year to date and +20.89% over one year to Jun 2026. Annualised returns are +8.00% over 3 years and +3.86% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $126, against $138 for the category, and to $121 over one year, against $137. Volatility over the past three years was 13.95% a year. In the 12 months to Jun 2026 the fund lost a net $3.7M, and assets reached $19.42M.
RYHIX Growth of $100
What $100 invested in Health Care Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | RYHIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $121 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $126 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $121 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $176 | $182 |
RYHIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.68% |
| 1 year | +20.89% |
| 3 years (annualised) | +8.00% |
| 5 years (annualised) | +3.86% |
RYHIX Annual Returns
Calendar-year total returns of Health Care Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +5.68% |
| 2025 | +14.44% |
| 2024 | +0.61% |
| 2023 | +5.84% |
| 2022 | −11.60% |
| 2021 | +19.23% |
| 2020 | +18.93% |
| 2019 (Jul–Dec) | +8.89% |
RYHIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.6% | +1.5% | −6.6% | +1.0% | +2.5% | +7.1% | — | — | — | — | — | — |
| 2025 | +6.8% | −1.3% | −2.9% | −2.5% | −2.0% | +2.3% | −2.6% | +5.2% | +2.3% | +4.2% | +7.5% | −2.6% |
| 2024 | +1.5% | +3.1% | +2.4% | −5.6% | +1.8% | +1.3% | +3.7% | +3.9% | −1.8% | −4.6% | +1.9% | −6.2% |
| 2023 | +1.3% | −3.8% | +2.2% | +2.5% | −4.5% | +4.9% | +0.6% | −1.0% | −4.1% | −5.2% | +6.6% | +7.2% |
| 2022 | −8.8% | −0.7% | +3.7% | −8.0% | +0.3% | −3.3% | +5.5% | −6.2% | −4.8% | +8.6% | +5.8% | −2.5% |
| 2021 | +3.8% | −2.6% | +1.2% | +4.7% | +0.3% | +4.6% | +3.7% | +2.2% | −5.1% | +3.4% | −4.4% | +6.7% |
| 2020 | −2.7% | −5.4% | −6.4% | +13.6% | +5.6% | −1.1% | +5.7% | +1.0% | −0.8% | −1.9% | +8.5% | +3.3% |
| 2019 | — | — | — | — | — | — | −1.0% | −2.8% | −0.8% | +4.5% | +6.8% | +2.1% |
RYHIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.95%
- 3-year Sharpe ratio: 0.25 (vs 4.5% risk-free rate)
- Best month: +7.55% (Nov 2025)
- Worst month: −6.63% (Mar 2026)
RYHIX Fund Flows
Monthly money in and out of Health Care Fund, from SEC Form N-PORT.
- 12-month net flow: −$3.7M
- 12-month gross sales (incl. reinvestments): $52.3M
- Sales ÷ redemptions: 0.93×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $3.9M | $4.1M | −$255K |
| May 2026 | $9.1M | $9.8M | −$703K |
| Apr 2026 | $1.9M | $2.7M | −$814K |
| Mar 2026 | $1.3M | $134K | $1.1M |
| Feb 2026 | $1.2M | $2.7M | −$1.5M |
| Jan 2026 | $5.2M | $2.6M | $2.6M |
| Dec 2025 | $2.9M | $8.6M | −$5.7M |
| Nov 2025 | $4.8M | $2.3M | $2.5M |
| Oct 2025 | $4.2M | $9.3M | −$5.1M |
| Sep 2025 | $3.0M | $8.5M | −$5.5M |
| Aug 2025 | $12.9M | $1.9M | $11.0M |
| Jul 2025 | $1.9M | $3.2M | −$1.3M |
RYHIX Assets Under Management
Net assets of Health Care Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $19.42M |
| 2026-03-31 | $19.25M |
| 2025-12-31 | $17.90M |
| 2025-09-30 | $24.49M |
| 2025-06-30 | $19.29M |
| 2025-03-31 | $24.39M |
| 2024-12-31 | $22.53M |
| 2024-09-30 | $25.12M |
| 2024-06-30 | $25.48M |
| 2024-03-31 | $24.73M |
| 2023-12-31 | $22.80M |
| 2023-09-30 | $21.94M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.